Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 61Stomach Neoplasms 10HER2-positive Breast Cancer 7Colorectal Neoplasms 6Neoplasm Metastasis 5Inflammatory Breast Neoplasms 3Breast Diseases 3Brain Neoplasms 3Pathologic Complete Response 2Neoplasms 2Esophageal Squamous Cell Carcinoma 2Cardiotoxicity 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Relapsed Pediatric Solid Tumor 1Pancreatic Neoplasms 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Invasive Breast Cancer 1Intestinal Neoplasms 1HER2-positive Metastatic Breast Cancer 1HER2-positive Gastric Cancer 1HER2-positive 1HER2+ Early or Locally Advanced Breast Cancer 1HER2+ Breast Cancer 1HER2 Positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Feasibility 1Estrogen Receptor-positive Breast Cancer 1

Interventions

Oxaliplatin 4Gemcitabine 4Fluorouracil 3Capecitabine 3Tegafur 2Stents 2Radiofrequency Ablation 2Leucovorin 2Irinotecan 2toripalimab 1tislelizumab 1taxane 1surufatinib 1lenvatinib 1apixaban 1apatinib 1aldesleukin 1Urination 1Trastuzumab 1Tomography, X-Ray Computed 1Temozolomide 1Taxes 1Standard of Care 1Sorafenib 1S 1 (combination) 1Rivaroxaban 1Radiotherapy 1Polymerase Chain Reaction 1Platinum Compounds 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gallbladder Neoplasms × Trastuzumab × Clear all
NCT02836847 2018-05-07

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
152 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡